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FD&C Yellow No. 6 (Sunset Yellow FCF, CAS
No. 2783-94-0), a water-soluble monoazo dye, has
been used since 1929 to impart a reddish-yellow
color to various gelatin desserts, sherbets, carbon-
ated beverages, candies, cereals, jams, pickles,
smoked fish, puddings, medicinals (liquids, tablets,
and capsules), toothpastes, hair rinses, and other
foods, drugs, and cosmetics.
The Carcinogenesis Testing Program, National
Cancer Institute (now part ofthe National Institute
of Environmental Health Sciences/National Toxi-
cology Program) selected and initiated a carcino-
genesis bioassay on FD&C Yellow No. 6 because
this chemical has wide use as a food colorant and in
myriad other consumer products, indicating low
level yet repeated exposure to a sizable population.
Further, results available from other studies were
considered inadequate for conclusive evaluation
due to the small numbers of animals, low dose
levels, and short exposure periods (1-4).
Methods
Male and female inbred Fischer 344 rats and male
and female hybrid B6C3F1 mice, obtained from the
Frederick Cancer Research Center, were used in
this study. Control and treatment groups contained
50 animals of each sex and species, except for the
control groups for rats, which consisted of90 males
and 90 females. For 103 consecutive weeks all
groups received Ralston Purina Laboratory Chow
meals. Treated groups were fed this diet containing
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1.25% (12,500 ppm) or 2.5% (25,000 ppm) FD&C
Yellow No. 6 (92% pure).
This carcinogenesis bioassay was conducted dur-
ing December 1976-January 1979 at the Battelle
Columbus Laboratories under a subcontract to
Tracor Jitco (prime contractor for the program).
All animals that died during the study or that
were killed at the end of the exposure period were
subjected to a gross necropsy and a complete
histopathological examination. Statistical analyses
comparing survival and numbers of animals with
specific site tumors were done with trend tests and
pairwise comparisons (5-8). The study design con-
formed to the NCI Guidelines for carcinogen bioas-
say (9).
Results
Mean body weights of high dose female rats and
all low dose groups were comparable to the con-
trols. High dose male rats and high dose male and
female mice weighed somewhat less (10% or less)
than the controls. Survival was comparable among
all groups.
The incidences of FD&C Yellow No. 6-treated
animals with specific site tumors did not differ
significantly fromthoseobservedincontrols. Tables
1 (rats) and 2 (mice) list those primary tumors
occurringin atleastthree animals ofany one group.
Discussion
Hepatocellular carcinomas occurred in low dose
(12,500 ppm) male mice at an incidence significantly
higher than that in the controls (13/50, 26%; 22/48,
46%; p < 0.05; 16/50, 32%); departure from linear
trend was likewise evident (p < 0.05), due mainly
to a higher incidence in the low dose group. The
historical control incidence (868/3,543, 24%) is sim-210 CONDENSATION
Table 1. Primary tumors in male and female F344 rats fed diets containing FD&C Yellow No. 6.
Males Females
Tumor Control 12,500 ppm 25,000 ppm Control 12,500 ppm 25,000 ppm
Adrenal cortical adenoma 3/89 2/50 0/49 6/86 2/50 4/50
Adrenal pheochromocytoma 14/89 3/50 11/49 4/86 1/50 4/50
Hepatocellular neoplastic nodule 5/90 6/50 1/50 3/88 3/50 0/50
Leukemia 22/90 12/50 17/50 16/88 12/50 10/50
Mammary gland 2/90 1/50 4/50 22/88 9/50 10/50
Pancreatic islet-cell adenoma or 3/88 4/49 2/49 1/83 1/50 0/50
carcinoma
Pituitary chromophobe adenoma or 5/84 5/46 4/46 30/83 18/45 17/48
carcinoma
Sucutaneous fibroma or fibrosarcoma 5/90 2/50 3/50 2/88 0/50 0/50
Testicular interstitial cell 86/90 48/50 50/50 - - -
Thyroid C-cell carcinoma 2/89 4/49 4/50 3/86 2/50 2/48
Uterine endometrial stromal polyp - - - 9/87 6/49 7/49
Table 2. Primary tumors in male and female B6C3F1 mice fed diets containing FD&C Yellow No. 6.
Males Females
Tumor Control 12,500 ppm 25,000 ppm Control 12,500 ppm 25,000 ppm
Lymphoma 9/50 1/49 10/50 15/50 5/50 10/49
Lung alveolar/bronchiolar adenoma 6/50 4/48 3/50 0/50 1/50 1/48
or carcinoma
Hepatocellular adenoma 1/50 1/48 0/50 1/48 3/50 0/48
Hepatocellular carcinoma 13/50 22/48 16/50 7/48 0/50 4/48
Pituitary chromophobe adenoma or 0/43 0/40 0/37 0/46 4/43 1/35
carcinoma
Skin and subcutaneous fibroma 5/50 5/49 6/50 0/50 0/50 0/49
or sarcoma
ilar to the control rate in this study. Because the
incidence ofhepatocellular carcinomas inthe 25,000
ppm group was not statistically different from
controls and because the liver tumor occurrence in
male B6C3F1 mice is variable, the increased num-
ber ofmales with liver carcinoma cannot be clearly
related to administration of FD&C Yellow No. 6.
Similarly, no other neoplastic or nonneoplastic
lesions were considered induced by or associated
with the administration of FD&C Yellow No. 6.
Therefore, under the conditions of this bioassay,
there was no clear evidence of carcinogenicity of
FD&C Yellow No. 6in F344 rats orB6C3F1 mice of
either sex (10).
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